| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
H3 histone pseudogene 8 | 0.544 | 0.808 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | |||||||||
|
H3 histone pseudogene 47 | 0.603 | 0.538 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
MAS related GPR family member X3 | 0.529 | 0.923 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
MAS related GPR family member X4 | 0.531 | 0.923 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.547 | 0.731 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | |||||||||
|
diacylglycerol kinase kappa | 0.780 | 0.385 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
ankyloblepharon filiforme adnatum | 0.792 | 0.462 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
MAS related GPR family member X1 | 0.531 | 0.923 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
Radial ray deficiency | 0.805 | 0.154 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
glaucoma 3, primary infantile, B | 0.769 | 0.154 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | |||||||||
|
homeobox A cluster | 0.599 | 0.654 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
homeobox B cluster | 0.631 | 0.538 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
homeobox C cluster | 0.695 | 0.462 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
endogenous retrovirus group MER61 member 1 | 0.890 | 0.115 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | |||||||||
|
glaucoma 3, primary congenital, C | 1.000 | 0.115 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | |||||||||
|
microRNA 200c | 0.486 | 0.846 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
miR-17-92a-1 cluster host gene | 0.483 | 0.808 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
vomeronasal 1 receptor 17 pseudogene | 0.529 | 0.923 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
G protein-coupled receptor 166 pseudogene | 0.531 | 0.923 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
tRNA | 0.534 | 0.731 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
orofacial cleft 2 | 0.931 | 0.115 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | |||||||||
|
mediator of cell motility 1 | 0.705 | 0.346 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
platelet and endothelial cell adhesion molecule 1 | 0.426 | 0.846 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 |